DES, Cancer, and Endocrine Disruptors: Ways of Regulating, Chemical Risks, and Public Expertise in the United States. Gaudillière, J. In Boudia, S. & Jas, N., editors, Powerless Science?, of Science and Politics in a Toxic World, pages 65–94. Berghahn Books, 1 edition, 2014. ![DES, Cancer, and Endocrine Disruptors: Ways of Regulating, Chemical Risks, and Public Expertise in the United States [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper abstract bibtex On 17 July 1979\textlessem\textgreaterThe New York Times\textless/em\textgreaterannounced that the New York State Supreme Court found the pharmaceutical company Eli Lilly responsible for the vaginal cancer affecting Joyce Bichler and awarded the young woman $500,000 in compensation.¹ The New York state ruling was the first legal decision recognizing that pharmaceutical firms, rather than physicians or regulatory authorities, were liable for the adverse consequences of the medical uses of diethylstilbestrol (DES). This analog of estrogen had been prescribed to millions of pregnant women in the United States as a safety measure against the risk of miscarriage for thirty years, until
@incollection{gaudilliere__2014,
edition = {1},
series = {Science and {Politics} in a {Toxic} {World}},
title = {{DES}, {Cancer}, and {Endocrine} {Disruptors}: {Ways} of {Regulating}, {Chemical} {Risks}, and {Public} {Expertise} in the {United} {States}},
isbn = {978-1-78238-236-2},
url = {http://www.jstor.org/stable/j.ctt9qd0tj.8},
abstract = {On 17 July 1979{\textless}em{\textgreater}The New York Times{\textless}/em{\textgreater}announced that the New York State Supreme Court found the pharmaceutical company Eli Lilly responsible for the vaginal cancer affecting Joyce Bichler and awarded the young woman \$500,000 in compensation.¹ The New York state ruling was the first legal decision recognizing that pharmaceutical firms, rather than physicians or regulatory authorities, were liable for the adverse consequences of the medical uses of diethylstilbestrol (DES). This analog of estrogen had been prescribed to millions of pregnant women in the United States as a safety measure against the risk of miscarriage for thirty years, until},
urldate = {2023-03-30},
booktitle = {Powerless {Science}?},
publisher = {Berghahn Books},
author = {Gaudillière, Jean-Paul},
editor = {Boudia, Soraya and Jas, Nathalie},
year = {2014},
keywords = {6 Ignorance and public policies, PRINTED (Fonds papier)},
pages = {65--94},
}
Downloads: 0
{"_id":"mdvzyjhxHXEstsFnv","bibbaseid":"gaudillire-descancerandendocrinedisruptorswaysofregulatingchemicalrisksandpublicexpertiseintheunitedstates-2014","author_short":["Gaudillière, J."],"bibdata":{"bibtype":"incollection","type":"incollection","edition":"1","series":"Science and Politics in a Toxic World","title":"DES, Cancer, and Endocrine Disruptors: Ways of Regulating, Chemical Risks, and Public Expertise in the United States","isbn":"978-1-78238-236-2","url":"http://www.jstor.org/stable/j.ctt9qd0tj.8","abstract":"On 17 July 1979\\textlessem\\textgreaterThe New York Times\\textless/em\\textgreaterannounced that the New York State Supreme Court found the pharmaceutical company Eli Lilly responsible for the vaginal cancer affecting Joyce Bichler and awarded the young woman $500,000 in compensation.¹ The New York state ruling was the first legal decision recognizing that pharmaceutical firms, rather than physicians or regulatory authorities, were liable for the adverse consequences of the medical uses of diethylstilbestrol (DES). This analog of estrogen had been prescribed to millions of pregnant women in the United States as a safety measure against the risk of miscarriage for thirty years, until","urldate":"2023-03-30","booktitle":"Powerless Science?","publisher":"Berghahn Books","author":[{"propositions":[],"lastnames":["Gaudillière"],"firstnames":["Jean-Paul"],"suffixes":[]}],"editor":[{"propositions":[],"lastnames":["Boudia"],"firstnames":["Soraya"],"suffixes":[]},{"propositions":[],"lastnames":["Jas"],"firstnames":["Nathalie"],"suffixes":[]}],"year":"2014","keywords":"6 Ignorance and public policies, PRINTED (Fonds papier)","pages":"65–94","bibtex":"@incollection{gaudilliere__2014,\n\tedition = {1},\n\tseries = {Science and {Politics} in a {Toxic} {World}},\n\ttitle = {{DES}, {Cancer}, and {Endocrine} {Disruptors}: {Ways} of {Regulating}, {Chemical} {Risks}, and {Public} {Expertise} in the {United} {States}},\n\tisbn = {978-1-78238-236-2},\n\turl = {http://www.jstor.org/stable/j.ctt9qd0tj.8},\n\tabstract = {On 17 July 1979{\\textless}em{\\textgreater}The New York Times{\\textless}/em{\\textgreater}announced that the New York State Supreme Court found the pharmaceutical company Eli Lilly responsible for the vaginal cancer affecting Joyce Bichler and awarded the young woman \\$500,000 in compensation.¹ The New York state ruling was the first legal decision recognizing that pharmaceutical firms, rather than physicians or regulatory authorities, were liable for the adverse consequences of the medical uses of diethylstilbestrol (DES). This analog of estrogen had been prescribed to millions of pregnant women in the United States as a safety measure against the risk of miscarriage for thirty years, until},\n\turldate = {2023-03-30},\n\tbooktitle = {Powerless {Science}?},\n\tpublisher = {Berghahn Books},\n\tauthor = {Gaudillière, Jean-Paul},\n\teditor = {Boudia, Soraya and Jas, Nathalie},\n\tyear = {2014},\n\tkeywords = {6 Ignorance and public policies, PRINTED (Fonds papier)},\n\tpages = {65--94},\n}\n\n","author_short":["Gaudillière, J."],"editor_short":["Boudia, S.","Jas, N."],"key":"gaudilliere__2014","id":"gaudilliere__2014","bibbaseid":"gaudillire-descancerandendocrinedisruptorswaysofregulatingchemicalrisksandpublicexpertiseintheunitedstates-2014","role":"author","urls":{"Paper":"http://www.jstor.org/stable/j.ctt9qd0tj.8"},"keyword":["6 Ignorance and public policies","PRINTED (Fonds papier)"],"metadata":{"authorlinks":{}}},"bibtype":"incollection","biburl":"http://bibbase.org/zotero-group/science_et_ignorance/1340424","dataSources":["zX4acseCDM6D58AW7","5XkfmA9xajmKjWGio"],"keywords":["6 ignorance and public policies","printed (fonds papier)"],"search_terms":["des","cancer","endocrine","disruptors","ways","regulating","chemical","risks","public","expertise","united","states","gaudillière"],"title":"DES, Cancer, and Endocrine Disruptors: Ways of Regulating, Chemical Risks, and Public Expertise in the United States","year":2014}